Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TGF-beta receptor type II and fetuin in the developing sheep neocortex

K M Dziegielewska1, R T Williams, G W Knott

  • 1Department of Anatomy and Physiology, University of Tasmania, GPO Box 252-24, Hobart 7001, Tasmania, Australia.

Cell and Tissue Research
|February 7, 1998
PubMed
Summary

Fetuin and TGF-beta type II receptor (TbetaR-II) have complementary, not overlapping, distribution patterns in the developing sheep neocortex. This finding challenges the proposed role of fetuin as a TGF-beta antagonist.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between maternal schizophrenia and risk of serious asthma exacerbations in childhood.

Schizophrenia research·2024
Same author

Bullous Amyloidosis as a cutaneous feature of Familial Lysozyme Amyloidosis.

The Australasian journal of dermatology·2024
Same author

Breakthrough COVID-19 is mild in vaccinated patients with hematological malignancy receiving tixagevimab-cilgavimab as pre-exposure prophylaxis.

Leukemia & lymphoma·2023
Same author

The ABCD stop signal data: Response to Bissett et al.

Developmental cognitive neuroscience·2022
Same author

Complex chronic conditions among children born to women with schizophrenia.

Schizophrenia research·2022
Same author

Efflux transporters in rat placenta and developing brain: transcriptomic and functional response to paracetamol.

Scientific reports·2021

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Molecular Biology

Background:

  • Fetuin is expressed in developing mammalian neocortex, primarily in cortical plate and subplate neurons.
  • Fetuin shares sequence homology with TGF-beta type II receptor (TbetaR-II) and binds TGF-beta cytokines in vitro.
  • Fetuin has been hypothesized to be a biological antagonist of TGF-beta cytokines.

Purpose of the Study:

  • To compare the distribution patterns of TbetaR-II and fetuin in the developing neocortex of fetal sheep.
  • To investigate the consistency of fetuin's proposed role as a TGF-beta antagonist with its distribution relative to TbetaR-II.

Main Methods:

  • Immunocytochemistry was used to visualize the distribution of TbetaR-II and fetuin in fetal sheep neocortex at various gestational ages.

Related Experiment Videos

  • Double-labeling techniques were employed to assess cellular co-localization of fetuin and TbetaR-II.

    • Main Results:

    • TbetaR-II immunoreactivity appeared in distinct bands in the developing sheep neocortex, with specific temporal and spatial localization.
    • The developmental expression pattern of TbetaR-II was found to be complementary, rather than overlapping, to that of fetuin.
    • While some cellular co-localization was observed, most fetuin-positive cells did not immunoreact for TbetaR-II.

    Conclusions:

    • The observed complementary distribution of fetuin and TbetaR-II in the developing sheep neocortex contradicts the hypothesis of fetuin acting as a direct antagonist or mimic of TbetaR-II.
    • Fetuin's proposed biological role as a TGF-beta antagonist is not supported by its spatiotemporal expression relative to TbetaR-II during neocortical development.